Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 29Unknown 2Terminated 2Active not recruiting 1

Sponsor Class

NIH 10OTHER 5NETWORK 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 2

Conditions

Breast Neoplasms 13Leukemia, Myeloid, Acute 12Colorectal Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms 6Head and Neck Neoplasms 6Fallopian Tube Neoplasms 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leukemia 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Vulvar Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma 3Liver Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Fatigue 3Depression 3Central Nervous System Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Stress Disorders, Post-Traumatic 2Small Cell Lung Carcinoma 2

Interventions

Temozolomide 2lonafarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × NETWORK × Gliosarcoma × Clear all
NCT00083096 2015-02-10

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Unknown
30 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00516607 2015-02-10

Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Unknown
28 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡